Disease/Infection News

RSS

Rare disease diagnosis available in days not years: BIA announcement

It currently takes 5 years on average to diagnose a child with a rare genetic disease, so he or she can receive the most appropriate care. This is set to change with an agreement facilitated by Northern Health Science Alliance (NHSA) between Congenica and 5 of its member hospitals, which will see them adopt the company’s world leading Sapientia™ technology.

16 Oct 2015

Native Antigen Co. announces the launch of a new range of Dengue Virus-Like Particles

Virus-Like Particles (VLPs) represent an increasingly important technology for use in vaccine development and serology. VLPs consist of protein shells comprising outer proteins specific to the virus in question.

16 Oct 2015

Traces of Ebola can linger in semen for nine months

Fragments of the Ebola virus can persist in the semen of survivors for as long as nine months after symptoms first develop, according to a study published in the New England Journal of Medicine.

15 Oct 2015

Neutrophils kill invading microorganisms, starve microbes to death

The most frequent immune cells in the human blood, so-called neutrophils, efficiently kill invading microorganisms and slowly starve microbes to death by removing crucial trace elements. This is shown by researchers from Umeå University in Sweden in a study published in a special issue of Metallomics.

15 Oct 2015

Researchers reveal effects of Affordable Care Act on low-income Virginians with HIV

In an important examination of the effect of the Affordable Care Act, researchers have determined that low-income Virginians with HIV had better outcomes when enrolled in Affordable Care Act healthcare plans. The study is believed to be the first to compare Affordable Care Act outcomes with the previous standard of care for this vulnerable patient population.

15 Oct 2015

Ebola virus can linger in semen of some men nine months after onset of symptoms

Preliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms.

15 Oct 2015

UTEP researchers patent low-cost device that can easily track health of HIV patients

University of Texas at El Paso researchers have patented a low-cost device that can easily monitor the health of HIV patients living in low-resource settings.

14 Oct 2015

First-ever genomic study shows dengue may survive year-round in southern China

The first-ever comprehensive genomic analysis of the virus that causes dengue fever suggests that it may survive year-round in southern China.

14 Oct 2015

Introduction of Ebola treatment beds reduces large number of deaths, Ebola cases in Sierra Leone

The introduction of thousands of Ebola treatment beds by the UK and Sierra Leone governments and NGOs prevented an estimated 57,000 Ebola cases and 40,000 deaths in Sierra Leone, according to new research published in the Proceedings of the National Academy of Sciences.

14 Oct 2015

Tips to treat, prevent common warts

Warts aren't just for witches and goblins. According to member dermatologists from the American Academy of Dermatology, children and teens, people who frequently bite their nails, and people with a weakened immune system are more prone to getting warts than others.

14 Oct 2015

Drug-resistant E. coli infections on the rise in community hospitals

Drug-resistant E. coli infections are on the rise in community hospitals, where more than half of U.S. patients receive their health care, according to a new study from Duke Medicine.

14 Oct 2015

Investigational antiviral drug effectively treats Lassa virus infection in guinea pigs

Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health scientists and colleagues.

13 Oct 2015

Bacterium that causes Q fever associated with increased risk of lymphoma

The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study published online today in Blood, the Journal of the American Society of Hematology.

13 Oct 2015

Malaria protein could one day help stop cancer

Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

13 Oct 2015

Danish researchers face possible breakthrough in fight against cancer

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim for tests on humans within four years.

13 Oct 2015

Get your flu shot before fall festivities, says Loyola infectious disease specialist

While planning your family's fall festivities this month, add the flu shot to the list. Then follow through with a visit to your doctor to make sure everyone is protected for the flu season. October is the recommended month to receive the vaccine for your best shot at preventing the flu.

13 Oct 2015

Tamoxifen drug clears MRSA, reduces mortality

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.

13 Oct 2015

Men on effective HIV therapy less likely to get HBV infection, shows research

Previous studies of individuals with HIV have suggested that HIV drug regimens that included drugs active against hepatitis B virus (HBV) can decrease the risk of infection with the liver-damaging HBV.

13 Oct 2015

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.

12 Oct 2015

FDA orders three duodenoscope manufacturers in the U.S. to conduct postmarket surveillance studies

The U.S. Food and Drug Administration today ordered the three manufacturers of duodenoscopes marketed in the U.S. to conduct postmarket surveillance studies to better understand how the devices are reprocessed in real-world settings.

12 Oct 2015

Disease/Infection News

Rare disease diagnosis available in days not years: BIA announcement

Native Antigen Co. announces the launch of a new range of Dengue Virus-Like Particles

Traces of Ebola can linger in semen for nine months

Neutrophils kill invading microorganisms, starve microbes to death

Researchers reveal effects of Affordable Care Act on low-income Virginians with HIV

Ebola virus can linger in semen of some men nine months after onset of symptoms

UTEP researchers patent low-cost device that can easily track health of HIV patients

First-ever genomic study shows dengue may survive year-round in southern China

Introduction of Ebola treatment beds reduces large number of deaths, Ebola cases in Sierra Leone

Tips to treat, prevent common warts

Drug-resistant E. coli infections on the rise in community hospitals

Investigational antiviral drug effectively treats Lassa virus infection in guinea pigs

Bacterium that causes Q fever associated with increased risk of lymphoma

Malaria protein could one day help stop cancer

Danish researchers face possible breakthrough in fight against cancer

Get your flu shot before fall festivities, says Loyola infectious disease specialist

Tamoxifen drug clears MRSA, reduces mortality

Men on effective HIV therapy less likely to get HBV infection, shows research

Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection

FDA orders three duodenoscope manufacturers in the U.S. to conduct postmarket surveillance studies

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News